Patent · US Active

Compositions and methods of using modified release solabegron for lower urinary tract symptoms

US9956194B2 · kind B2 · utility

14Cited by

19References

60Claims

0Family size

Assignee

Velicept Therapeutics, Inc. · US

Inventors

Eliot Ohlstein · Glenmoore, US
Raymond E. STEVENS · West Chester, US
H. Jeffrey Wilkins · Sellersville, US

Key dates

Filing date	Dec 3, 2015
Grant date	May 1, 2018
Priority date	—
Expiry date	Dec 3, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This application relates to pharmaceutical compositions, comprising solabegron that are useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to methods for treating lower urinary tract symptoms utilizing the pharmaceutical compositions, comprising solabegron. In some embodiments, the pharmaceutical compositions, comprising solabegron comprise a dual release drug delivery system.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.